HIV drug resistance and risk factors associated with first-line regimen failure in Maputo and Tete, Mozambique
Principal investigator
-
Location
-
Topic
-
Methodology
-
ReferenceOCB1715
Purpose of study
Purpose of study
The global scale-up of antiretroviral therapy has led to a growing number of people under treatment, notably in sub-Saharan Africa. Despite good short-term health outcomes, antiretroviral therapy (ART) roll-out is accelerating the number of pati...
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
Publication added by Petros Isaakidis
26th April 2023 -
Concept paper added by Petros Isaakidis
12th April 20231188-concept-paper-2023-04-12.docx1.33 MB -
ERB documentation added by Petros Isaakidis
12th April 20231188-erb-documentation-2023-04-12.doc64.5 KB
Documents
Publications
-
High level of HIV drug resistance informs dolutegravir roll-out and optimized NRTI backbone strategy in MozambiqueCarnimeo, V "–" Oxford University Press (OUP) "(2021)"
Previous study
Next study